EUVIMEDEUVIMED entdecken
Open Access

Pneumonic Plague Protection Induced by a Monophosphoryl Lipid A Decorated Yersinia Outer‐Membrane‐Vesicle Vaccine

Saugata Majumder, Shreya Das, Peng Li, Nicole Yang, Hazel Dellario, Haixin Sui, Ziqiang Guan, Wei Sun iD

Small · 2024

DOI: 10.1002/smll.202307066 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, 2024. Verfasst von Saugata Majumder und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Microbial Disease, Albany Medical College, Albany, NY, 12208, USA. Hauptthemen laut MEDLINE: Plague, Plague Vaccine, Yersinia pestis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A new Yersinia pseudotuberculosis mutant strain, YptbS46, carrying the lpxE insertion and pmrF‐J deletion is constructed and shown to exclusively produce monophosphoryl lipid A (MPLA) having adjuvant properties. Outer membrane vesicles (OMVs) isolated from YptbS46 harboring an lcrV expression plasmid, pSMV13, are designated OMV 46 ‐LcrV, which contained MPLA and high amounts of LcrV (Low Calcium response V) and displayed low activation of Toll‐like receptor 4 (TLR4). Intramuscular prime‐boost immunization with 30 µg of of OMV 46 ‐LcrV exhibited substantially reduced reactogenicity than the parent OMV 44 ‐LcrV and conferred complete protection to mice against a high‐dose of respiratory Y. pestis challenge. OMV 46 ‐LcrV immunization induced robust adaptive responses in both lung mucosal and systemic compartments and orchestrated innate immunity in the lung, which are correlated with rapid bacterial clearance and unremarkable lung damage during Y. pestis challenge. Additionally, OMV 46 ‐LcrV immunization conferred long‐term protection. Moreover, immunization with reduced doses of OMV 46 ‐LcrV exhibited further lower reactogenicity and still provided great protection against pneumonic plague. The studies strongly demonstrate the feasibility of OMV 46 ‐LcrV as a new type of plague vaccine candidate.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PlaguePlague VaccineYersinia pestisMiceAnimalsYersiniaAntigens, BacterialLipid A

Stichwörter der Autor:innen

OUTER membrane vesiclesY. pestismonophosphoryl lipid Aplague vaccineprotective immunity

Substanzen

monophosphoryl lipid APlague VaccineAntigens, BacterialLipid A

Autor:innen und Institutionen

  • Department of Immunology and Microbial Disease, Albany Medical College, Albany, NY, 12208, USA.
  • Wadsworth Center, New York State Department of Health, Albany, NY, 12237, USA.
  • Department of Biochemistry, Duke University Medical Center, Durham, NC, 27710, USA.

ORCID-Profile: Wei Sun

Förderung

  • NIGMS NIH HHS
  • NIH HHS
  • NIAID NIH HHS
  • National Institutes of Health

Zitieren

APA

Majumder, S., Das, S., Li, P., Yang, N., Dellario, H., Sui, H., Guan, Z., & Sun, W. (2024). Pneumonic Plague Protection Induced by a Monophosphoryl Lipid A Decorated Yersinia Outer‐Membrane‐Vesicle Vaccine. Small. https://doi.org/10.1002/smll.202307066

Vancouver

Majumder S, Das S, Li P, Yang N, Dellario H, Sui H, et al. Pneumonic Plague Protection Induced by a Monophosphoryl Lipid A Decorated Yersinia Outer‐Membrane‐Vesicle Vaccine. Small. 2024. doi:10.1002/smll.202307066

BibTeX
@article{Majumder2024,
  author = {Majumder, Saugata and Das, Shreya and Li, Peng and Yang, Nicole and Dellario, Hazel and Sui, Haixin and Guan, Ziqiang and Sun, Wei},
  title = {Pneumonic Plague Protection Induced by a Monophosphoryl Lipid A Decorated Yersinia Outer‐Membrane‐Vesicle Vaccine},
  journal = {Small},
  year = {2024},
  doi = {10.1002/smll.202307066}
}
Kostenlos starten →